Cached score snapshot

US.BAX · Baxter International

110分制 54.9/110;5D動能v2 31/50;排序分 85.9/160

Ranking score 85.9/160
Main score 54.9/110
5D momentum v2 31/50
Rank #96
Setup grade D 43.4

Score breakdown

避免

Medium twelvedata

Score and price trend

D 43.4 Technical A · Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 05-01 06-26 08-05 08-24 09-08 $15.59$22.02$28.44 Price Projection date
Historical projection
Model Median P25/P75 Win rate Down5 Actual / compare
Rolling DOE best · score 2.475 · anchors 120 -0.24% -2.03% / +1.64% 46.2% 6.2% Actual outcome pending · 0 / 3 bars observed
30D observation +2.97% -3.85% / +9.06% 61.4% 22.6% Actual outcome pending · 0 / 30 bars observed
Historical projection 10D n=160 -0.36% -2.31% / +1.53% 41.9% 3.8% Actual outcome pending · 0 / 10 bars observed

Historical projection is based on archived similar setups. It is not a recommendation or guaranteed forecast.

2026-05-01 → 2026-09-08 · 150 archived points · 3 Improving turn signal · 6 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 85.9
Display grade 避免
Model version cursor_18_27_news_v2_160
Main score 54.9/110 (避免)
5D momentum v2 31/50 (強)
Score with momentum v2 85.9/160 (低排序)
Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 60
ma20 22.422
ma50 20.7564
close 24.37
prevClose 23.34
avgVolume20 5556704
volumeRatio 1.06
changePercent 4.41

Metrics snapshot

close 24.37
volume 5884277
changePercent 4.41

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 54.9/110
Main rating 避免
5D momentum v2 31/50
Score with momentum v2 85.9/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 2.1/5 · 較差

Dimension score 2.1/5
Dimension grade 較差

Sub-items

pbPoints 0.5
pePoints 0
epsPoints 0
roePoints 0
debtPoints 0.4
marginPoints 0
turnoverUsdM 143.3998
volumePoints 0.5
revenuePoints 0
dividendPoints 0.3
marketCapPoints 0.4

資金流 — 13.2/20 · 一般

Dimension score 13.2/20
Dimension grade 一般

Sub-items

cmfPoints 1.6
mfiPoints 3.2
obvPoints 3.2
vwapPoints 3.2

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.BAX
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 5.4/15 · 較差

Dimension score 5.4/15
Dimension grade 較差

Sub-items

vix

score 1.8

details

source twelvedata+fred
vixClose 18.67

trend

score 0.8

details

qqq

ma20 708.0635
ma50 716.7494
name QQQ
close 675.49
points 0.4

spy

ma20 746.651
ma50 744.8574
name SPY
close 740.86
points 0.4
source twelvedata+fred
atrPct 3.4731
atrPoints 2
cciPoints 0.8
vixPoints 1.8
marketTrendPoints 0.8

催化劑 — 2/20 · 較差

Dimension score 2/20
Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model
articleCount 6
catalystCount 0
catalystPoints 2

風險管理 — 6.7/10 · 一般

Dimension score 6.7/10
Dimension grade 一般

Sub-items

position

score 1.1

details

atrPct 3.4731
turnoverUsdM 143.3998
liquidityPoints 0.4
volatilityPoints 0.7
rrPoints 1.8

stopLevels

symbol US.BAX
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 22.6772

strength_details

ma_score 1.5
atr_score 1
rsi_score 3
macd_score 3
volume_score 2
market_adjustment 1
risk_reward_ratio 1.6
stop_loss_percent 6.9
take_profit_price 27.1011
target_multiplier 2.2
technical_strength 2.2
take_profit_percent 11.2
positionPoints 1.1
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.6124
stopLossPercent 6.9462
diversificationPoints 2

技術信號 — 22.5/30 · 良好

Dimension score 22.5/30
Dimension grade 良好

Sub-items

bbPoints 3
adxPoints 3
sarPoints 2.4
vcpPoints 1.5
macdPoints 4

vcpPayload

vcp_pass false
vcp_score 1.5
vcp_reason 跌縮量(近10日3日);站上MA50;收盤突破20日高位;Ready=N;Confirm=Y

vcp_metrics

up_days 5
vol_ref 6086650
down_days 4
vcp_ready false
above_ma50 true
avg_vol_10 5195640
avg_vol_20 5548595
avg_vol_30 6086650
range_pct_10 0.1046
range_pct_20 0.1046
range_pct_30 0.1777
up_expand_ok false
lookback_used 59
near_20d_high true
contraction_ok false
down_shrink_ok true
up_expand_days 1
breakout_20d_ok true
vol_ratio_10_30 0.8536
dist_to_20d_high -0.0278
down_shrink_days 3
breakout_level_20d 23.71
vcp_breakout_confirm true
contraction_ratio_10_30 0.5889
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction false
kdjAdxPoints 0.8
rsiKdjPoints 3.2
volumeWeight 2
maCrossPoints 1.6
shortRsiPoints 0.8
shortMacdPoints 0.4
volConfirmPoints 0.6
volumePointsTechnical 1.2

情緒分析 — 3/10 · 較差

Dimension score 3/10
Dimension grade 較差

Sub-items

sentiment

score 3

details

source finnhub_news_keyword_model
articleCount 6
negativeHits 0
positiveHits 1
sentimentScoreRaw 0.4

sentimentData

raw {"id":141040357,"url":"https://finnhub.io/api/news?id=5b68a5449756cb77be3fa60595d044e46a65ddbdfc31c42aaf32c9ebd37c7990","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Shares of healthcare company Baxter International (NYSE:BAX) jumped 3.6% in the afternoon session after TD Cowen raised its price target on the stock to $24 from $20. The firm maintained its hold rating on the shares, which suggests the analyst recommends neither buying nor selling the stock at its current price. However, the increased price target indicates a more positive valuation outlook for the company than before. The move from the investment firm comes as Baxter holds an average rating of","category":"company","datetime":1785211982,"headline":"Why Baxter (BAX) Stock Is Up Today"}, {"id":140995061,"url":"https://finnhub.io/api/news?id=db23a00dbadf1632408d3346471e8697b520ed9dfae62199e89d17d199b750c0","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Baxter (BAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.","category":"company","datetime":1784815204,"headline":"Earnings Preview: Baxter International (BAX) Q2 Earnings Expected to Decline"}, {"id":140922903,"url":"https://finnhub.io/api/news?id=b5275a01614690b3553f7d84214cfd6f5edddbea6d87e4155056cc235f474a0d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Baxter trades at $22.13 and has moved in lockstep with the market. Its shares have returned 10% over the last six months while the S&P 500 has gained 8.7%.","category":"company","datetime":1784222962,"headline":"3 Reasons to Avoid BAX and 1 Stock to Buy Instead"}, {"id":140831700,"url":"https://finnhub.io/api/news?id=bdca05e54b73cce68bcbc92c7d914a17c17db63875e119cfbd3541b5bc33a5fa","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Index additions put fresh attention on Baxter International Baxter International (BAX) has been added to both the Russell 2500 Index and the Russell 2500 Value Benchmark, a shift that can influence index tracking flows and bring the stock onto more investor radars. See our latest analysis for Baxter International. Recent price action reflects that attention. Baxter International’s share price is US$22.58, with a 30-day share price return of 16.51% and a 90-day share price return of 35.86%...","category":"company","datetime":1783437460,"headline":"Is Baxter International (BAX) Fully Valued On Its Russell 2500 Index Additions?"}, {"id":140831701,"url":"https://finnhub.io/api/news?id=540300aef1039a0c5f3bd5176a5e695e538aba143d506b23c7473b2ff6b6d9db","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Baxter International Inc. was recently added to both the Russell 2500 Index and the Russell 2500 Value Benchmark, expanding its presence among US equity indices and index-tracking portfolios. This dual index inclusion, combined with broadly positive sentiment and supportive near- and mid-term outlooks, has drawn fresh attention from institutional investors and quantitative trading strategies focused on the stock. We’ll now examine how Baxter’s new Russell 2500 inclusion, alongside...","category":"company","datetime":1783433501,"headline":"Will Dual Russell 2500 Inclusion and Stronger Sentiment Change Baxter International's (BAX) Narrative?"}, {"id":140832327,"url":"https://finnhub.io/api/news?id=1f2f9710c3a6500f798e20b31ccf18aa99dd02281a5083045d6a3118b8c9bdf9","image":"https://image.cnbcfm.com/api/v1/image/108331141-17833752641783375262-47000887666-1080pnbcnews.jpg?v=1783375263&w=1920&h=1080","source":"CNBC","related":"BAX","summary":"CNBC’s “Fast Money” team shares their final trades of the day.","category":"company","datetime":1783361006,"headline":"Final Trade: BAX, TSLA, DRAM, GDX"}
raw_source {"id":141050066,"url":"https://finnhub.io/api/news?id=5821b8f0699b65c18a1faaa7007cc8787772feced6cf9d55e9eb04dd75ed0ffd","image":"","source":"Benzinga","related":"BAX","summary":"UBS analyst Patrick Wood maintains Baxter International (NYSE:BAX) with a Neutral and raises the price target from $19 to $25.","category":"company","datetime":1785251655,"headline":"UBS Maintains Neutral on Baxter International, Raises Price Target to $25"}, {"id":141050067,"url":"https://finnhub.io/api/news?id=22bc36b9d33d7b2e004987b217f7709abeeefa0b8d64f9064e5fec5baa41815d","image":"","source":"Benzinga","related":"BAX","summary":"Stifel analyst Rick Wise maintains Baxter International (NYSE:BAX) with a Hold and raises the price target from $19 to $24.","category":"company","datetime":1785235324,"headline":"Stifel Maintains Hold on Baxter International, Raises Price Target to $24"}, {"id":141040357,"url":"https://finnhub.io/api/news?id=5b68a5449756cb77be3fa60595d044e46a65ddbdfc31c42aaf32c9ebd37c7990","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Shares of healthcare company Baxter International (NYSE:BAX) jumped 3.6% in the afternoon session after TD Cowen raised its price target on the stock to $24 from $20. The firm maintained its hold rating on the shares, which suggests the analyst recommends neither buying nor selling the stock at its current price. However, the increased price target indicates a more positive valuation outlook for the company than before. The move from the investment firm comes as Baxter holds an average rating of","category":"company","datetime":1785211982,"headline":"Why Baxter (BAX) Stock Is Up Today"}, {"id":141038252,"url":"https://finnhub.io/api/news?id=f4a4559b5b850caa4d2b8b4706d2fff61de0ed7a357e903f58d4b8e4681acf97","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.","category":"company","datetime":1785192302,"headline":"3 Unprofitable Stocks That Fall Short"}, {"id":141034536,"url":"https://finnhub.io/api/news?id=92dcb8ac7576fe5ff634c1d302510a6bc71b737f528929fdca6bf34d39670d18","image":"","source":"Benzinga","related":"BAX","summary":"TD Cowen analyst Joshua Jennings maintains Baxter International (NYSE:BAX) with a Hold and raises the price target from $20 to $24.","category":"company","datetime":1785149154,"headline":"TD Cowen Maintains Hold on Baxter International, Raises Price Target to $24"}, {"id":141008023,"url":"https://finnhub.io/api/news?id=f8f30bf84e1e15f6f6e57395b4c780f642075ee558f77c259033ceff89883108","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"BAX's second-quarter results may reflect pressured earnings and sales as manufacturing inefficiencies, inflation, and product holds offset steady demand across segments.","category":"company","datetime":1784906460,"headline":"Will Baxter's Q2 Results Continue to Reflect Operational Headwinds?"}, {"id":140995061,"url":"https://finnhub.io/api/news?id=db23a00dbadf1632408d3346471e8697b520ed9dfae62199e89d17d199b750c0","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Baxter (BAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.","category":"company","datetime":1784815204,"headline":"Earnings Preview: Baxter International (BAX) Q2 Earnings Expected to Decline"}, {"id":140981107,"url":"https://finnhub.io/api/news?id=6ac2b5933542dcd98e2e2e1302ec766992726916b32e83acad878ea4b34b42ae","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.","category":"company","datetime":1784716707,"headline":"1 S&P 500 Stock for Long-Term Investors and 2 We Find Risky"}, {"id":140948764,"url":"https://finnhub.io/api/news?id=242adb6d5a3818f92451aceba654f7dc3d15514ebe1a5e1a61b2d0cacef77720","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1323873733/image_1323873733.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"BAX","summary":"Baxter (BAX) stock rebounds 21% YTD after Q1 beat, but debt and muted growth cap upside near $22 fair value.","category":"company","datetime":1784413326,"headline":"Baxter: The Chart Points Higher, Valuation And Growth Are Less Appealing"}, {"id":140922903,"url":"https://finnhub.io/api/news?id=b5275a01614690b3553f7d84214cfd6f5edddbea6d87e4155056cc235f474a0d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Baxter trades at $22.13 and has moved in lockstep with the market. Its shares have returned 10% over the last six months while the S&P 500 has gained 8.7%.","category":"company","datetime":1784222962,"headline":"3 Reasons to Avoid BAX and 1 Stock to Buy Instead"}, {"id":140920976,"url":"https://finnhub.io/api/news?id=76bc23d4d790ded7e25ac854371641c9f43064d0b6f2a5978ce3830dc769912b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Abbott’s (ABT) latest financial disclosure reveals a significant strategic evolution that market participants often overlook amidst the focus on quarterly beats. The company is actively executing a structural pivot, shifting its capital allocation and growth dependency away from the volatile Nutrition segment toward high-margin, innovation-led MedTech and specialized diagnostics.","category":"company","datetime":1784210345,"headline":"Why Abbott Stock Is Reimagining Its Future"}, {"id":140049019,"url":"https://finnhub.io/api/news?id=7a629db8b449d905f61c4ffdf1b6684b342fcc22ebf1c524d64b1d845debb6ed","image":"","source":"Benzinga","related":"BAX","summary":"","category":"company","datetime":1784205329,"headline":"Carlsmed Announces Aprevo Bi-Lateral Posterior Lumbar Interbody Fusion Procedure"}, {"id":140907456,"url":"https://finnhub.io/api/news?id=ea90e871f4bebe869edd06014cb31d2873975e46465444a66adc34fbae80de5c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"AbbVie and Baxter both flashed the same bullish technical signal this month, but one golden cross signals genuine momentum while the other masks a fundamentally broken business. Knowing which is which could protect your retirement income from a costly mistake.","category":"company","datetime":1784115954,"headline":"AbbVie vs Baxter: One Golden Cross Is Real, One Is a Trap"}, {"id":140915088,"url":"https://finnhub.io/api/news?id=ab284d63df7e87bf80758c01d9b8b65a5e3132d2aceaecdc57a9a6705ec6b0eb","image":"","source":"Benzinga","related":"BAX","summary":"Goldman Sachs analyst David Roman maintains Baxter International (NYSE:BAX) with a Neutral and raises the price target from $19 to $21.","category":"company","datetime":1784114662,"headline":"Goldman Sachs Maintains Neutral on Baxter International, Raises Price Target to $21"}, {"id":140907548,"url":"https://finnhub.io/api/news?id=89532ae5ac01cfa76fe574eb412f71bd7fa0e7e53888b0375cda378132492a48","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.","category":"company","datetime":1784113757,"headline":"3 Cash-Producing Stocks with Warning Signs"}, {"id":140897584,"url":"https://finnhub.io/api/news?id=e89def7c0ac59e2c2278d3bdc4ee12a87bb928101e8b6a227c378a65a8572717","image":"https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp","source":"ChartMill","related":"BAX","summary":"Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Tuesday. Stay informed about the latest market trends.","category":"company","datetime":1784039701,"headline":"What's going on in today's session: S&P500 gap up and gap down stocks"}, {"id":140091407,"url":"https://finnhub.io/api/news?id=4f3bae5f1a4e13b081552f7770afdce76cba0f5763322ce7524be732ab5f910f","image":"","source":"Benzinga","related":"BAX","summary":"","category":"company","datetime":1784034450,"headline":"Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation"}, {"id":140855921,"url":"https://finnhub.io/api/news?id=c3f1d29647d50538eea9159bdbb5db19431b7ed59cddc8ed4d114a14f39489ac","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"DEERFIELD, Ill., July 09, 2026--Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its second-quarter 2026 financial results on Thursday, July 30, 2026, at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://events.q4inc.com/attendee/167756971 to pre-register for the call and receive the call information.","category":"company","datetime":1783627800,"headline":"Baxter to Host Second-Quarter 2026 Financial Results Conference Call for Investors"}, {"id":140851034,"url":"https://finnhub.io/api/news?id=fbd429437af6da7e6d6db2fb997ec0ff61cd8b8ed5974cd91a1292b6aa3b7500","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Retia Medical, the developer of cardiovascular intelligence software that transforms routine physiologic monitoring data into actionable clinical insight, today announced the appointment of Christopher Benassi, former Vice President, Connected Care Group at Baxter International, to its Strategic Advisory Board.","category":"company","datetime":1783601580,"headline":"Retia Medical Appoints Christopher Benassi to Strategic Advisory Board"}, {"id":140850105,"url":"https://finnhub.io/api/news?id=ce0913844bbfe462e69b9fb5cc1739fbf15ce70eb94ca1ed4fb38cc13cb73b83","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 10% over the past six months, topping the S&P 500 by 2.3 percentage points.","category":"company","datetime":1783597740,"headline":"3 Healthcare Stocks We Think Twice About"}, {"id":140843626,"url":"https://finnhub.io/api/news?id=943d08e631e5a9f541203c25926fd77cae5bf3f6b369a5ad404685a382eaa2e4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Baxter International will release its second-quarter earnings soon, and analysts anticipate a double-digit profit dip.","category":"company","datetime":1783509287,"headline":"Baxter International's Q2 2026 Earnings: What to Expect"}, {"id":140831700,"url":"https://finnhub.io/api/news?id=bdca05e54b73cce68bcbc92c7d914a17c17db63875e119cfbd3541b5bc33a5fa","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Index additions put fresh attention on Baxter International Baxter International (BAX) has been added to both the Russell 2500 Index and the Russell 2500 Value Benchmark, a shift that can influence index tracking flows and bring the stock onto more investor radars. See our latest analysis for Baxter International. Recent price action reflects that attention. Baxter International’s share price is US$22.58, with a 30-day share price return of 16.51% and a 90-day share price return of 35.86%...","category":"company","datetime":1783437460,"headline":"Is Baxter International (BAX) Fully Valued On Its Russell 2500 Index Additions?"}, {"id":140831701,"url":"https://finnhub.io/api/news?id=540300aef1039a0c5f3bd5176a5e695e538aba143d506b23c7473b2ff6b6d9db","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Baxter International Inc. was recently added to both the Russell 2500 Index and the Russell 2500 Value Benchmark, expanding its presence among US equity indices and index-tracking portfolios. This dual index inclusion, combined with broadly positive sentiment and supportive near- and mid-term outlooks, has drawn fresh attention from institutional investors and quantitative trading strategies focused on the stock. We’ll now examine how Baxter’s new Russell 2500 inclusion, alongside...","category":"company","datetime":1783433501,"headline":"Will Dual Russell 2500 Inclusion and Stronger Sentiment Change Baxter International's (BAX) Narrative?"}, {"id":140829561,"url":"https://finnhub.io/api/news?id=83610d15f24312f54f0fce106677a786905765f5e1d75b5c1c3e9744ed6f2559","image":"https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp","source":"ChartMill","related":"BAX","summary":"Pre-market stock analysis of S&P500 stocks on 2026-07-07: top gainers and losers in today's session.","category":"company","datetime":1783427701,"headline":"These S&P500 stocks are moving in today's pre-market session"}, {"id":140829303,"url":"https://finnhub.io/api/news?id=109ba7dd5aadf6a7767ddcfc93f90bfa91be93081fd9491b160ccae52fe40c77","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason — five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.","category":"company","datetime":1783419952,"headline":"3 Value Stocks We Keep Off Our Radar"}, {"id":140832327,"url":"https://finnhub.io/api/news?id=1f2f9710c3a6500f798e20b31ccf18aa99dd02281a5083045d6a3118b8c9bdf9","image":"https://image.cnbcfm.com/api/v1/image/108331141-17833752641783375262-47000887666-1080pnbcnews.jpg?v=1783375263&w=1920&h=1080","source":"CNBC","related":"BAX","summary":"CNBC’s “Fast Money” team shares their final trades of the day.","category":"company","datetime":1783361006,"headline":"Final Trade: BAX, TSLA, DRAM, GDX"}, {"id":140823137,"url":"https://finnhub.io/api/news?id=551923397eb0a7116ba7714942d334cfe2da380823998a5a044d2bd8c05bddcf","image":"","source":"Benzinga","related":"BAX","summary":"Evercore ISI Group analyst Vijay Kumar maintains Baxter International (NYSE:BAX) with a Outperform and raises the price target from $22 to $24.","category":"company","datetime":1783338012,"headline":"Evercore ISI Group Maintains Outperform on Baxter International, Raises Price Target to $24"}, {"id":140802850,"url":"https://finnhub.io/api/news?id=c5905c968be2d149392bf23b184b1bb711768e2b822b0fb6621edca56d2e06a8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"WST has surged nearly 33% YTD as strong earnings, GLP-1 demand and biologics growth fuel momentum that could extend through 2026.","category":"company","datetime":1783100460,"headline":"WST Stock Up Nearly 33% YTD: Will the Uptrend Continue in the Rest of 2026?"}, {"id":140792023,"url":"https://finnhub.io/api/news?id=1b2cfcadbb8d51bc8a515709b049fcc4c163eaecd6b9d58fce0cdcc7a1a170b7","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"BAX","summary":"Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.","category":"company","datetime":1783010101,"headline":"These S&P500 stocks are moving in today's session"}, {"id":140773587,"url":"https://finnhub.io/api/news?id=b14d8a4a4df572ec5dd36dfce74c378ba4cad7af2cf47b716a9de2ed4398ade2","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"CorMedix broadens beyond DefenCath with Melinta assets, Rezzayo potential and cost synergies as reimbursement changes test long-term earnings durability.","category":"company","datetime":1782832200,"headline":"CRMD's Growth Story Expands Beyond DefenCath Into New Trends"}, {"id":140765129,"url":"https://finnhub.io/api/news?id=3b510a05254eac4da2d0a1d40f52879e479eca6c746029ac93824db3dbb6fbc7","image":"https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_2.jpg?width=2048&height=1536","source":"Benzinga","related":"BAX","summary":"This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often","category":"company","datetime":1782740122,"headline":"10 Health Care Stocks With Whale Alerts In Today’s Session"}, {"id":140760997,"url":"https://finnhub.io/api/news?id=37f97fddf6554d546f7bb0d63aeba15b5d903c4d4968ff489d3e16554f75df15","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"BAX","summary":"Nate Baxter Appointed President and Chief Executive Officer Pete Shumlin Elected Chairman of the Board MARYSVILLE, Ohio, June 29, 2026 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE: SMG), the leading marketer of branded consumer lawn and garden products in North America, today announced that the Board of Directors has named Nate Baxter as president and CEO, effective immediately. In addition, Baxter has joined the Board of Directors. The Board also elected independent Lead Director Pe","category":"company","datetime":1782730500,"headline":"ScottsMiracle-Gro Announces Strategic Leadership Succession"}
data_source finnhub_news_keyword_model
article_count 6
negative_hits 0
positive_hits 1
recomputed_at_score true
sentiment_score_raw 0.4
source_article_count 32
discarded_article_count 26
sentimentPoints 3

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 2.1 5/110 42% 2.1
資金流 13.2 20/110 66% 13.2
市場環境 5.4 15/110 36% 5.4
催化劑 2 20/110 10% 2
風險管理 6.7 10/110 67% 6.7
技術信號 22.5 30/110 75% 22.5
情緒分析 3 10/110 30% 3

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 31/50
ret_5d 0.0973
max_score 50
max_total 50
raw_total 31
vcp_bonus 0
vol_ratio 1.0605
ret_points 12
vol_points 2
range_ratio 1.5547
volat_points 4
day_range_pct 0.0482
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 8
partial_history false
pullback_points 3
breakout_vol_bonus 0
first_breakout_20d true
return_window_days 5
first_breakout_bonus 2
breakout_quality_points 0

Risk management

level Medium
reason risk management score >= 6.5/10

position

score 1.1

details

atrPct 3.4731
turnoverUsdM 143.3998
liquidityPoints 0.4
volatilityPoints 0.7
rrPoints 1.8

stopLevels

symbol US.BAX
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 22.6772

strength_details

ma_score 1.5
atr_score 1
rsi_score 3
macd_score 3
volume_score 2
market_adjustment 1
risk_reward_ratio 1.6
stop_loss_percent 6.9
take_profit_price 27.1011
target_multiplier 2.2
technical_strength 2.2
take_profit_percent 11.2
positionPoints 1.1
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.6124
stopLossPercent 6.9462
diversificationPoints 2

Calculation audit log

基本面分析總分: 2.1/5分
資金流分析總分: 13.2/20分
市場環境分析總分: 5.4/15分
催化劑分析: 2/20分
風險管理總分: 6.7/10分
技術信號分析總分: 22.5/30分
情緒分析: 3/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 100
atr
atr 0.8464
rule ATR / current price; lower volatility scores higher
score 4
atr_pct 3.47
cci
rule Cursor_18.24 CCI bands
level 超買或超賣風險
score 2
value 250.34
cmf
rule Cursor_18.24 CMF bands
level 平衡
score 4
value 0.023
kdj
d 52.33
j 91.15
k 65.27
rule Cursor_18.24 K/D cross
score 6
signal 強金叉
mfi
rule Cursor_18.24 MFI bands
level 入貨中
score 8
value 66.56
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 8
trend 資金入貨
value 78902877
recentSlope 666167.7
previousSlope 597650
rsi
value 65.58
sar
rule Cursor_18.24 Parabolic SAR
score 8
trend 上升
value 21.2048
position SAR喺價下
distancePct 12.99
previousTrend 上升
ma50
value 20.7564
macd
macd 0.645
trend 強烈看漲
signal 0.6118
histogram 0.0332
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 8
value 22.4373
position 連續3日>VWAP
consecutiveAbove 3
volume
rule Cursor_18.24 volume ratio
level 有量
ratio 1.06
score 6
avgVolume 5556704
currentVolume 5884277
derived
ma20 22.422
ma50 20.7564
prevClose 23.34
avgVolume10 5279338
avgVolume20 5556704
changePercent 4.41
avgVolumeForScore 5556704
ma_cross
ma20 22.422
ma50 20.7564
rule Cursor_18.24 MA20/MA50 cross
cross 多頭
score 4
prevMa20 22.3045
prevMa50 20.6246
spreadPct 8.02
isVolumeBreakout false
bollinger
lower 21.0456
upper 23.7984
position 上半部
rsi_short
value 84.02
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 1.06

Raw calculation JSON

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.1,
      "details": {
        "atrPct": 3.4731226918342224,
        "turnoverUsdM": 143.39983049,
        "liquidityPoints": 0.4,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.8,
    "stopLevels": {
      "symbol": "US.BAX",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 22.6772,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 1,
        "rsi_score": 3,
        "macd_score": 3,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.6,
      "stop_loss_percent": 6.9,
      "take_profit_price": 27.1011,
      "target_multiplier": 2.2,
      "technical_strength": 2.2,
      "take_profit_percent": 11.2
    },
    "positionPoints": 1.1,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.6123818525519849,
    "stopLossPercent": 6.946245383668445,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 85.9,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 54.9,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 31
  },
  "market": {
    "ma20": 22.422,
    "ma50": 20.7564,
    "close": 24.37,
    "prevClose": 23.34,
    "avgVolume20": 5556704,
    "volumeRatio": 1.06,
    "changePercent": 4.41
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 31,
    "details": {
      "ret_5d": 0.09725348941918055,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 31,
      "vcp_bonus": 0,
      "vol_ratio": 1.0604985586441251,
      "ret_points": 12,
      "vol_points": 2,
      "range_ratio": 1.554742718868595,
      "volat_points": 4,
      "day_range_pct": 0.04821501846532625,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 8,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": true,
      "return_window_days": 5,
      "first_breakout_bonus": 2,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 85.9,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.1,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 42,
        "contribution": 2.1
      },
      {
        "raw": 13.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 66,
        "contribution": 13.2
      },
      {
        "raw": 5.4,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 36,
        "contribution": 5.4
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.7,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 67,
        "contribution": 6.7
      },
      {
        "raw": 22.5,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 75,
        "contribution": 22.5
      },
      {
        "raw": 3,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 30,
        "contribution": 3
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 54.9,
    "details": [
      "基本面分析總分: 2.1/5分",
      "資金流分析總分: 13.2/20分",
      "市場環境分析總分: 5.4/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.7/10分",
      "技術信號分析總分: 22.5/30分",
      "情緒分析: 3/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.1,
      "資金流": 13.2,
      "市場環境": 5.4,
      "情緒分析": 3,
      "技術信號": 22.5,
      "風險管理": 6.7
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 6,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.5,
          "pePoints": 0,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.4,
          "marginPoints": 0,
          "turnoverUsdM": 143.39983049,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.4
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "一般",
        "items": {
          "cmfPoints": 1.6,
          "mfiPoints": 3.2,
          "obvPoints": 3.2,
          "vwapPoints": 3.2,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.BAX",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 1.8,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 18.67
            }
          },
          "trend": {
            "score": 0.8,
            "details": {
              "qqq": {
                "ma20": 708.0634979000001,
                "ma50": 716.7494019999999,
                "name": "QQQ",
                "close": 675.48999,
                "points": 0.4
              },
              "spy": {
                "ma20": 746.6510067000002,
                "ma50": 744.8574021799999,
                "name": "SPY",
                "close": 740.85999,
                "points": 0.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 3.4731226918342224,
          "atrPoints": 2,
          "cciPoints": 0.8,
          "vixPoints": 1.8,
          "marketTrendPoints": 0.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 3,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 6,
              "negativeHits": 0,
              "positiveHits": 1,
              "sentimentScoreRaw": 0.4
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141040357,
                "url": "https://finnhub.io/api/news?id=5b68a5449756cb77be3fa60595d044e46a65ddbdfc31c42aaf32c9ebd37c7990",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Shares of healthcare company Baxter International (NYSE:BAX) jumped 3.6% in the afternoon session after TD Cowen raised its price target on the stock to $24 from $20. The firm maintained its hold rating on the shares, which suggests the analyst recommends neither buying nor selling the stock at its current price. However, the increased price target indicates a more positive valuation outlook for the company than before. The move from the investment firm comes as Baxter holds an average rating of",
                "category": "company",
                "datetime": 1785211982,
                "headline": "Why Baxter (BAX) Stock Is Up Today"
              },
              {
                "id": 140995061,
                "url": "https://finnhub.io/api/news?id=db23a00dbadf1632408d3346471e8697b520ed9dfae62199e89d17d199b750c0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Baxter (BAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1784815204,
                "headline": "Earnings Preview: Baxter International (BAX) Q2 Earnings Expected to Decline"
              },
              {
                "id": 140922903,
                "url": "https://finnhub.io/api/news?id=b5275a01614690b3553f7d84214cfd6f5edddbea6d87e4155056cc235f474a0d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Baxter trades at $22.13 and has moved in lockstep with the market. Its shares have returned 10% over the last six months while the S&P 500 has gained 8.7%.",
                "category": "company",
                "datetime": 1784222962,
                "headline": "3 Reasons to Avoid BAX and 1 Stock to Buy Instead"
              },
              {
                "id": 140831700,
                "url": "https://finnhub.io/api/news?id=bdca05e54b73cce68bcbc92c7d914a17c17db63875e119cfbd3541b5bc33a5fa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Index additions put fresh attention on Baxter International Baxter International (BAX) has been added to both the Russell 2500 Index and the Russell 2500 Value Benchmark, a shift that can influence index tracking flows and bring the stock onto more investor radars. See our latest analysis for Baxter International. Recent price action reflects that attention. Baxter International’s share price is US$22.58, with a 30-day share price return of 16.51% and a 90-day share price return of 35.86%...",
                "category": "company",
                "datetime": 1783437460,
                "headline": "Is Baxter International (BAX) Fully Valued On Its Russell 2500 Index Additions?"
              },
              {
                "id": 140831701,
                "url": "https://finnhub.io/api/news?id=540300aef1039a0c5f3bd5176a5e695e538aba143d506b23c7473b2ff6b6d9db",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Baxter International Inc. was recently added to both the Russell 2500 Index and the Russell 2500 Value Benchmark, expanding its presence among US equity indices and index-tracking portfolios. This dual index inclusion, combined with broadly positive sentiment and supportive near- and mid-term outlooks, has drawn fresh attention from institutional investors and quantitative trading strategies focused on the stock. We’ll now examine how Baxter’s new Russell 2500 inclusion, alongside...",
                "category": "company",
                "datetime": 1783433501,
                "headline": "Will Dual Russell 2500 Inclusion and Stronger Sentiment Change Baxter International's (BAX) Narrative?"
              },
              {
                "id": 140832327,
                "url": "https://finnhub.io/api/news?id=1f2f9710c3a6500f798e20b31ccf18aa99dd02281a5083045d6a3118b8c9bdf9",
                "image": "https://image.cnbcfm.com/api/v1/image/108331141-17833752641783375262-47000887666-1080pnbcnews.jpg?v=1783375263&w=1920&h=1080",
                "source": "CNBC",
                "related": "BAX",
                "summary": "CNBC’s “Fast Money” team shares their final trades of the day.",
                "category": "company",
                "datetime": 1783361006,
                "headline": "Final Trade: BAX, TSLA, DRAM, GDX"
              }
            ],
            "raw_source": [
              {
                "id": 141050066,
                "url": "https://finnhub.io/api/news?id=5821b8f0699b65c18a1faaa7007cc8787772feced6cf9d55e9eb04dd75ed0ffd",
                "image": "",
                "source": "Benzinga",
                "related": "BAX",
                "summary": "UBS  analyst Patrick Wood   maintains Baxter International (NYSE:BAX) with a Neutral and raises the price target from $19 to $25.",
                "category": "company",
                "datetime": 1785251655,
                "headline": "UBS Maintains Neutral on Baxter International, Raises Price Target to $25"
              },
              {
                "id": 141050067,
                "url": "https://finnhub.io/api/news?id=22bc36b9d33d7b2e004987b217f7709abeeefa0b8d64f9064e5fec5baa41815d",
                "image": "",
                "source": "Benzinga",
                "related": "BAX",
                "summary": "Stifel  analyst Rick Wise   maintains Baxter International (NYSE:BAX) with a Hold and raises the price target from $19 to $24.",
                "category": "company",
                "datetime": 1785235324,
                "headline": "Stifel Maintains Hold on Baxter International, Raises Price Target to $24"
              },
              {
                "id": 141040357,
                "url": "https://finnhub.io/api/news?id=5b68a5449756cb77be3fa60595d044e46a65ddbdfc31c42aaf32c9ebd37c7990",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Shares of healthcare company Baxter International (NYSE:BAX) jumped 3.6% in the afternoon session after TD Cowen raised its price target on the stock to $24 from $20. The firm maintained its hold rating on the shares, which suggests the analyst recommends neither buying nor selling the stock at its current price. However, the increased price target indicates a more positive valuation outlook for the company than before. The move from the investment firm comes as Baxter holds an average rating of",
                "category": "company",
                "datetime": 1785211982,
                "headline": "Why Baxter (BAX) Stock Is Up Today"
              },
              {
                "id": 141038252,
                "url": "https://finnhub.io/api/news?id=f4a4559b5b850caa4d2b8b4706d2fff61de0ed7a357e903f58d4b8e4681acf97",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.",
                "category": "company",
                "datetime": 1785192302,
                "headline": "3 Unprofitable Stocks That Fall Short"
              },
              {
                "id": 141034536,
                "url": "https://finnhub.io/api/news?id=92dcb8ac7576fe5ff634c1d302510a6bc71b737f528929fdca6bf34d39670d18",
                "image": "",
                "source": "Benzinga",
                "related": "BAX",
                "summary": "TD Cowen  analyst Joshua Jennings   maintains Baxter International (NYSE:BAX) with a Hold and raises the price target from $20 to $24.",
                "category": "company",
                "datetime": 1785149154,
                "headline": "TD Cowen Maintains Hold on Baxter International, Raises Price Target to $24"
              },
              {
                "id": 141008023,
                "url": "https://finnhub.io/api/news?id=f8f30bf84e1e15f6f6e57395b4c780f642075ee558f77c259033ceff89883108",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "BAX's second-quarter results may reflect pressured earnings and sales as manufacturing inefficiencies, inflation, and product holds offset steady demand across segments.",
                "category": "company",
                "datetime": 1784906460,
                "headline": "Will Baxter's Q2 Results Continue to Reflect Operational Headwinds?"
              },
              {
                "id": 140995061,
                "url": "https://finnhub.io/api/news?id=db23a00dbadf1632408d3346471e8697b520ed9dfae62199e89d17d199b750c0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Baxter (BAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1784815204,
                "headline": "Earnings Preview: Baxter International (BAX) Q2 Earnings Expected to Decline"
              },
              {
                "id": 140981107,
                "url": "https://finnhub.io/api/news?id=6ac2b5933542dcd98e2e2e1302ec766992726916b32e83acad878ea4b34b42ae",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.",
                "category": "company",
                "datetime": 1784716707,
                "headline": "1 S&P 500 Stock for Long-Term Investors and 2 We Find Risky"
              },
              {
                "id": 140948764,
                "url": "https://finnhub.io/api/news?id=242adb6d5a3818f92451aceba654f7dc3d15514ebe1a5e1a61b2d0cacef77720",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1323873733/image_1323873733.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "BAX",
                "summary": "Baxter (BAX) stock rebounds 21% YTD after Q1 beat, but debt and muted growth cap upside near $22 fair value.",
                "category": "company",
                "datetime": 1784413326,
                "headline": "Baxter: The Chart Points Higher, Valuation And Growth Are Less Appealing"
              },
              {
                "id": 140922903,
                "url": "https://finnhub.io/api/news?id=b5275a01614690b3553f7d84214cfd6f5edddbea6d87e4155056cc235f474a0d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Baxter trades at $22.13 and has moved in lockstep with the market. Its shares have returned 10% over the last six months while the S&P 500 has gained 8.7%.",
                "category": "company",
                "datetime": 1784222962,
                "headline": "3 Reasons to Avoid BAX and 1 Stock to Buy Instead"
              },
              {
                "id": 140920976,
                "url": "https://finnhub.io/api/news?id=76bc23d4d790ded7e25ac854371641c9f43064d0b6f2a5978ce3830dc769912b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Abbott’s (ABT) latest financial disclosure reveals a significant strategic evolution that market participants often overlook amidst the focus on quarterly beats. The company is actively executing a structural pivot, shifting its capital allocation and growth dependency away from the volatile Nutrition segment toward high-margin, innovation-led MedTech and specialized diagnostics.",
                "category": "company",
                "datetime": 1784210345,
                "headline": "Why Abbott Stock Is Reimagining Its Future"
              },
              {
                "id": 140049019,
                "url": "https://finnhub.io/api/news?id=7a629db8b449d905f61c4ffdf1b6684b342fcc22ebf1c524d64b1d845debb6ed",
                "image": "",
                "source": "Benzinga",
                "related": "BAX",
                "summary": "",
                "category": "company",
                "datetime": 1784205329,
                "headline": "Carlsmed Announces Aprevo Bi-Lateral Posterior Lumbar Interbody Fusion Procedure"
              },
              {
                "id": 140907456,
                "url": "https://finnhub.io/api/news?id=ea90e871f4bebe869edd06014cb31d2873975e46465444a66adc34fbae80de5c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "AbbVie and Baxter both flashed the same bullish technical signal this month, but one golden cross signals genuine momentum while the other masks a fundamentally broken business. Knowing which is which could protect your retirement income from a costly mistake.",
                "category": "company",
                "datetime": 1784115954,
                "headline": "AbbVie vs Baxter: One Golden Cross Is Real, One Is a Trap"
              },
              {
                "id": 140915088,
                "url": "https://finnhub.io/api/news?id=ab284d63df7e87bf80758c01d9b8b65a5e3132d2aceaecdc57a9a6705ec6b0eb",
                "image": "",
                "source": "Benzinga",
                "related": "BAX",
                "summary": "Goldman Sachs  analyst David Roman   maintains Baxter International (NYSE:BAX) with a Neutral and raises the price target from $19 to $21.",
                "category": "company",
                "datetime": 1784114662,
                "headline": "Goldman Sachs Maintains Neutral on Baxter International, Raises Price Target to $21"
              },
              {
                "id": 140907548,
                "url": "https://finnhub.io/api/news?id=89532ae5ac01cfa76fe574eb412f71bd7fa0e7e53888b0375cda378132492a48",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.",
                "category": "company",
                "datetime": 1784113757,
                "headline": "3 Cash-Producing Stocks with Warning Signs"
              },
              {
                "id": 140897584,
                "url": "https://finnhub.io/api/news?id=e89def7c0ac59e2c2278d3bdc4ee12a87bb928101e8b6a227c378a65a8572717",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "BAX",
                "summary": "Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Tuesday. Stay informed about the latest market trends.",
                "category": "company",
                "datetime": 1784039701,
                "headline": "What's going on in today's session: S&P500 gap up and gap down stocks"
              },
              {
                "id": 140091407,
                "url": "https://finnhub.io/api/news?id=4f3bae5f1a4e13b081552f7770afdce76cba0f5763322ce7524be732ab5f910f",
                "image": "",
                "source": "Benzinga",
                "related": "BAX",
                "summary": "",
                "category": "company",
                "datetime": 1784034450,
                "headline": "Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation"
              },
              {
                "id": 140855921,
                "url": "https://finnhub.io/api/news?id=c3f1d29647d50538eea9159bdbb5db19431b7ed59cddc8ed4d114a14f39489ac",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "DEERFIELD, Ill., July 09, 2026--Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its second-quarter 2026 financial results on Thursday, July 30, 2026, at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://events.q4inc.com/attendee/167756971 to pre-register for the call and receive the call information.",
                "category": "company",
                "datetime": 1783627800,
                "headline": "Baxter to Host Second-Quarter 2026 Financial Results Conference Call for Investors"
              },
              {
                "id": 140851034,
                "url": "https://finnhub.io/api/news?id=fbd429437af6da7e6d6db2fb997ec0ff61cd8b8ed5974cd91a1292b6aa3b7500",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Retia Medical, the developer of cardiovascular intelligence software that transforms routine physiologic monitoring data into actionable clinical insight, today announced the appointment of Christopher Benassi, former Vice President, Connected Care Group at Baxter International, to its Strategic Advisory Board.",
                "category": "company",
                "datetime": 1783601580,
                "headline": "Retia Medical Appoints Christopher Benassi to Strategic Advisory Board"
              },
              {
                "id": 140850105,
                "url": "https://finnhub.io/api/news?id=ce0913844bbfe462e69b9fb5cc1739fbf15ce70eb94ca1ed4fb38cc13cb73b83",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 10% over the past six months, topping the S&P 500 by 2.3 percentage points.",
                "category": "company",
                "datetime": 1783597740,
                "headline": "3 Healthcare Stocks We Think Twice About"
              },
              {
                "id": 140843626,
                "url": "https://finnhub.io/api/news?id=943d08e631e5a9f541203c25926fd77cae5bf3f6b369a5ad404685a382eaa2e4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Baxter International will release its second-quarter earnings soon, and analysts anticipate a double-digit profit dip.",
                "category": "company",
                "datetime": 1783509287,
                "headline": "Baxter International's Q2 2026 Earnings: What to Expect"
              },
              {
                "id": 140831700,
                "url": "https://finnhub.io/api/news?id=bdca05e54b73cce68bcbc92c7d914a17c17db63875e119cfbd3541b5bc33a5fa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Index additions put fresh attention on Baxter International Baxter International (BAX) has been added to both the Russell 2500 Index and the Russell 2500 Value Benchmark, a shift that can influence index tracking flows and bring the stock onto more investor radars. See our latest analysis for Baxter International. Recent price action reflects that attention. Baxter International’s share price is US$22.58, with a 30-day share price return of 16.51% and a 90-day share price return of 35.86%...",
                "category": "company",
                "datetime": 1783437460,
                "headline": "Is Baxter International (BAX) Fully Valued On Its Russell 2500 Index Additions?"
              },
              {
                "id": 140831701,
                "url": "https://finnhub.io/api/news?id=540300aef1039a0c5f3bd5176a5e695e538aba143d506b23c7473b2ff6b6d9db",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Baxter International Inc. was recently added to both the Russell 2500 Index and the Russell 2500 Value Benchmark, expanding its presence among US equity indices and index-tracking portfolios. This dual index inclusion, combined with broadly positive sentiment and supportive near- and mid-term outlooks, has drawn fresh attention from institutional investors and quantitative trading strategies focused on the stock. We’ll now examine how Baxter’s new Russell 2500 inclusion, alongside...",
                "category": "company",
                "datetime": 1783433501,
                "headline": "Will Dual Russell 2500 Inclusion and Stronger Sentiment Change Baxter International's (BAX) Narrative?"
              },
              {
                "id": 140829561,
                "url": "https://finnhub.io/api/news?id=83610d15f24312f54f0fce106677a786905765f5e1d75b5c1c3e9744ed6f2559",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "BAX",
                "summary": "Pre-market stock analysis of S&P500 stocks on 2026-07-07: top gainers and losers in today's session.",
                "category": "company",
                "datetime": 1783427701,
                "headline": "These S&P500 stocks are moving in today's pre-market session"
              },
              {
                "id": 140829303,
                "url": "https://finnhub.io/api/news?id=109ba7dd5aadf6a7767ddcfc93f90bfa91be93081fd9491b160ccae52fe40c77",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason — five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.",
                "category": "company",
                "datetime": 1783419952,
                "headline": "3 Value Stocks We Keep Off Our Radar"
              },
              {
                "id": 140832327,
                "url": "https://finnhub.io/api/news?id=1f2f9710c3a6500f798e20b31ccf18aa99dd02281a5083045d6a3118b8c9bdf9",
                "image": "https://image.cnbcfm.com/api/v1/image/108331141-17833752641783375262-47000887666-1080pnbcnews.jpg?v=1783375263&w=1920&h=1080",
                "source": "CNBC",
                "related": "BAX",
                "summary": "CNBC’s “Fast Money” team shares their final trades of the day.",
                "category": "company",
                "datetime": 1783361006,
                "headline": "Final Trade: BAX, TSLA, DRAM, GDX"
              },
              {
                "id": 140823137,
                "url": "https://finnhub.io/api/news?id=551923397eb0a7116ba7714942d334cfe2da380823998a5a044d2bd8c05bddcf",
                "image": "",
                "source": "Benzinga",
                "related": "BAX",
                "summary": "Evercore ISI Group  analyst Vijay Kumar   maintains Baxter International (NYSE:BAX) with a Outperform and raises the price target from $22 to $24.",
                "category": "company",
                "datetime": 1783338012,
                "headline": "Evercore ISI Group Maintains Outperform on Baxter International, Raises Price Target to $24"
              },
              {
                "id": 140802850,
                "url": "https://finnhub.io/api/news?id=c5905c968be2d149392bf23b184b1bb711768e2b822b0fb6621edca56d2e06a8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "WST has surged nearly 33% YTD as strong earnings, GLP-1 demand and biologics growth fuel momentum that could extend through 2026.",
                "category": "company",
                "datetime": 1783100460,
                "headline": "WST Stock Up Nearly 33% YTD: Will the Uptrend Continue in the Rest of 2026?"
              },
              {
                "id": 140792023,
                "url": "https://finnhub.io/api/news?id=1b2cfcadbb8d51bc8a515709b049fcc4c163eaecd6b9d58fce0cdcc7a1a170b7",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "BAX",
                "summary": "Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.",
                "category": "company",
                "datetime": 1783010101,
                "headline": "These S&P500 stocks are moving in today's session"
              },
              {
                "id": 140773587,
                "url": "https://finnhub.io/api/news?id=b14d8a4a4df572ec5dd36dfce74c378ba4cad7af2cf47b716a9de2ed4398ade2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "CorMedix broadens beyond DefenCath with Melinta assets, Rezzayo potential and cost synergies as reimbursement changes test long-term earnings durability.",
                "category": "company",
                "datetime": 1782832200,
                "headline": "CRMD's Growth Story Expands Beyond DefenCath Into New Trends"
              },
              {
                "id": 140765129,
                "url": "https://finnhub.io/api/news?id=3b510a05254eac4da2d0a1d40f52879e479eca6c746029ac93824db3dbb6fbc7",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "BAX",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often",
                "category": "company",
                "datetime": 1782740122,
                "headline": "10 Health Care Stocks With Whale Alerts In Today’s Session"
              },
              {
                "id": 140760997,
                "url": "https://finnhub.io/api/news?id=37f97fddf6554d546f7bb0d63aeba15b5d903c4d4968ff489d3e16554f75df15",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "BAX",
                "summary": "Nate Baxter Appointed President and Chief Executive Officer Pete Shumlin Elected Chairman of the Board MARYSVILLE, Ohio, June 29, 2026 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE: SMG), the leading marketer of branded consumer lawn and garden products in North America, today announced that the Board of Directors has named Nate Baxter as president and CEO, effective immediately. In addition, Baxter has joined the Board of Directors. The Board also elected independent Lead Director Pe",
                "category": "company",
                "datetime": 1782730500,
                "headline": "ScottsMiracle-Gro Announces Strategic Leadership Succession"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 6,
            "negative_hits": 0,
            "positive_hits": 1,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.4,
            "source_article_count": 32,
            "discarded_article_count": 26
          },
          "sentimentPoints": 3
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 22.5,
        "grade": "良好",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 1.5,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1.5,
            "vcp_reason": "跌縮量(近10日3日);站上MA50;收盤突破20日高位;Ready=N;Confirm=Y",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 6086650,
              "down_days": 4,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 5195640,
              "avg_vol_20": 5548595,
              "avg_vol_30": 6086650,
              "range_pct_10": 0.10463684858432501,
              "range_pct_20": 0.10463684858432501,
              "range_pct_30": 0.17767747230201072,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 1,
              "breakout_20d_ok": true,
              "vol_ratio_10_30": 0.8536124140537077,
              "dist_to_20d_high": -0.02783635596794602,
              "down_shrink_days": 3,
              "breakout_level_20d": 23.71,
              "vcp_breakout_confirm": true,
              "contraction_ratio_10_30": 0.5889145496535796
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.8,
          "rsiKdjPoints": 3.2,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.8,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.1,
            "details": {
              "atrPct": 3.4731226918342224,
              "turnoverUsdM": 143.39983049,
              "liquidityPoints": 0.4,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.8,
          "stopLevels": {
            "symbol": "US.BAX",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 22.6772,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 1,
              "rsi_score": 3,
              "macd_score": 3,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.6,
            "stop_loss_percent": 6.9,
            "take_profit_price": 27.1011,
            "target_multiplier": 2.2,
            "technical_strength": 2.2,
            "take_profit_percent": 11.2
          },
          "positionPoints": 1.1,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.6123818525519849,
          "stopLossPercent": 6.946245383668445,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 100,
    "atr": {
      "atr": 0.8464,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 3.47
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 250.34
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "平衡",
      "score": 4,
      "value": 0.023
    },
    "kdj": {
      "d": 52.33,
      "j": 91.15,
      "k": 65.27,
      "rule": "Cursor_18.24 K/D cross",
      "score": 6,
      "signal": "強金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "入貨中",
      "score": 8,
      "value": 66.56
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 8,
      "trend": "資金入貨",
      "value": 78902877,
      "recentSlope": 666167.7,
      "previousSlope": 597650
    },
    "rsi": 65.58,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 21.2048,
      "position": "SAR喺價下",
      "distancePct": 12.99,
      "previousTrend": "上升"
    },
    "ma50": 20.7564,
    "macd": {
      "macd": 0.6450189798653412,
      "trend": "強烈看漲",
      "signal": 0.6118193730065365,
      "histogram": 0.03319960685880463
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 8,
      "value": 22.4373,
      "position": "連續3日>VWAP",
      "consecutiveAbove": 3
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.06,
      "score": 6,
      "avgVolume": 5556704,
      "currentVolume": 5884277
    },
    "derived": {
      "ma20": 22.422,
      "ma50": 20.7564,
      "prevClose": 23.34,
      "avgVolume10": 5279338,
      "avgVolume20": 5556704,
      "changePercent": 4.41,
      "avgVolumeForScore": 5556704
    },
    "ma_cross": {
      "ma20": 22.422,
      "ma50": 20.7564,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 22.3045,
      "prevMa50": 20.6246,
      "spreadPct": 8.02,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 21.0456,
      "upper": 23.7984,
      "position": "上半部"
    },
    "rsi_short": 84.02,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.06
    }
  }
}

Raw metrics JSON

{
  "close": 24.37,
  "volume": 5884277,
  "changePercent": 4.41
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.